Acne
Vulgaris Treatment Market, By Product Type (Medications and Devices) and by
Geography – Global Industry Insights, Trends, Outlook, and Opportunity
Analysis, 2018-2026
Acne vulgaris is a common skin
disease characterized by blackheads, whiteheads, papules, and pustules on the
face, neck, back, and chest. It is commonly observed in adolescent population,
however, can also affect adults. Depending on its severity, acne may be
segmented into mild, moderate or severe. It is caused due to excess oil
produced in sebaceous glands under skin, which becomes plugged and inflated.
Female patient with polycystic ovarian syndrome and even hormonal disorders
such as excess androgen production may suffer from acne as well. People with
acne vulgaris are usually characterized by social withdrawal, low self-esteem,
and depression with suicidal tendencies.
U.S. is expected to be the
largest market for acne vulgaris treatment products over the forecast period
According to a study published in
the British Journal of Dermatology in 2015, 9.4% of global population was
estimated to be affected by acne. Moreover, globally, acne is the eight most
prevalent disease. The U.S. is the largest market for acne vulgaris treatment
products. According to study by National Institute of Health (NIH), in 2013,
over US$ 3 Billion was spent for treating acne vulgaris in the U.S. In 2014,
according to American Academy of Dermatology, the number of acne vulgaris
patient aged 25 years and above, especially women, is rising
significantly. Furthermore, low
awareness regarding the factors causing acne is another factor leading to
increasing prevalence acne vulgaris.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1260
Treatment for acne on an average
lasts for two years, therefore companies capitalize on this and earn
sustainable revenue from acne treatment products. Majority of the population
suffering from acne prefer OTC products as first line therapy. However, some
have to visit dermatologist to cure acne vulgaris on account of ineffective
result from OTC products.
India is expected to have largest
pool of population in the age group 15–25 years by 2020. This, in turn, makes
it a highly lucrative market for acne vulgaris treatment products. India also
has high glycemic index diet, which is further expected to aid in growth of the
market over the forecast period. Manufacturers are also focusing on developing
products for scarring, resulting from acne. New treatments such as cosmetic
(laser, chemical peel, and photodynamic therapy) and surgical procedures are
been developed for treatment of scarring. Increasing consumer inclination
towards alternative way to treat acne vulgaris such as herbal therapy (tee tree
oil), owing to low side effects is another factor expected to aid in growth of
the acne vulgaris treatment market. Home-based devices for acne removal such as
revive light therapy and neutrogena light therapy are gaining significant traction
over the forecast period.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/acne-vulgaris-treatment-market-1260
Key players in the acne vulgaris
treatment market are focusing on collaboration, acquisition, and new product
development strategies in order to enhance their product offerings and
sustaining their position in the market. For instance, in 2017, L’Oréal — a
global beauty company — signed an agreement with Valeant Pharmaceuticals
International, Inc. to acquire its skin care brands portfolio which includes
anti-acne brand AcneFree at US$1.3 billion. Also, in November 2017 Novan Inc.,
announced its plans to conduct phase three clinical trial for its new anti-acne
molecule. Novan has unique nitric oxide technology, Nitrici, through which a
timed release of nitric oxide from chemical entity is possible. This is
beneficial as nitric oxide has natural ability to revitalize tissue, kill
invading microorganisms, prevent clotting, regulate inflammation, and even aid
in removing cancer cells. Moreover, in 2017, Valeant Pharmaceuticals
International, Inc. signed an agreement with Haitong International Zhonghua
Finance Acquisition Fund I, L.P, to sell its Obagi Medical Products business
for US$ 190 million in cash. Obagi Medical Products have high presence in acne treatment
products market.
Key players in the global acne
vulgaris treatment market are Allergan plc, GlaxoSmithKline plc, Valeant
Pharmaceutical International Inc., F.Hoffmann-La Roche AG, Mylan, N.V., Bayer
AG, Janssen Pharma Inc., Galderma Inc., Pfizer Inc., and Novan Inc.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1260
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment